Bristol-Myers Squibb Co (NYSE:BMY)

63.82
Delayed Data
As of Dec 13
 -0.12 / -0.19%
Today’s Change
42.48
Today|||52-Week Range
64.75
+22.78%
Year-to-Date
After Its Celgene Acquisition, Bristol-Myers Squibb's Future Looks Bright
Dec 12 / MotleyFool.com - Paid Partner Content
Better Buy: Pfizer vs. Bristol-Myers Squibb
Dec 08 / MotleyFool.com - Paid Partner Content
Here's Why You Should Own Amgen Stock in 2020
Dec 12 / MotleyFool.com - Paid Partner Content
Bristol Myers Squibb: A Cash-Generating Machine at a Cheap Price
Dec 07 / MotleyFool.com - Paid Partner Content
Heres Why bluebird bio Shares Jumped Almost 12% Today
Dec 10 / MotleyFool.com - Paid Partner Content
2 Breast Cancer Fighting Stocks to Invest In
Dec 06 / MotleyFool.com - Paid Partner Content
Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for Both
Dec 10 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks With a Lot to Prove at ASH 2019
Dec 02 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen vs. Amgen
Dec 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close63.94
Today’s open64.04
Day’s range63.79 - 64.75
Volume14,569,249
Average volume (3 months)15,011,047
Market cap$149.6B
Data as of 6:30pm ET, 12/13/2019

Growth & Valuation

Earnings growth (last year)+392.14%
Earnings growth (this year)+8.95%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+8.59%
P/E ratio18.4
Price/Sales3.77
Price/Book7.38

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.89-1.00%
AZNAstraZeneca+0.44+0.92%
SNYSanofi+0.28+0.57%
LLYEli Lilly and Co-0.17-0.14%
Data as of 6:30pm ET, 12/13/2019

Financials

Next reporting dateJanuary 27, 2020
EPS forecast (this quarter)$0.91
Annual revenue (last year)$22.6B
Annual profit (last year)$4.9B
Net profit margin21.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts